GENE ONLINE|News &
Opinion
Blog

Pembrolizumab
Merck’s Keytruda Bags FDA Approval for Early Kidney Cancer in Adjuvant Setting
2021-11-18
Day 2 ESMO 2021 Roundup: New Paradigms for Long-Term Cancer Care and Immunotherapies for High Risk Metastatic Cancers
2021-09-19
First Non-Gene Edited CAR-T to Partner with Merck’s Blockbuster Against Colorectal Cancer
2020-10-01
Keytruda Receives Two New Approvals in Japan
2020-08-30
Keytruda Wins Big in China, Now Approved for Esophageal Squamous Cell Carcinomas
2020-06-26
R&D
ASCO 2020: Keytruda Shines as New Quality of Care in Treating metastatic Colorectal Cancer
2020-06-03
R&D
ASCO 2020: Keytruda Chemo Combo Show Significant Benefit in PD-L1 Expressing mTNBC
2020-06-03
What to Expect from the ASCO20 Virtual Program
2020-05-29
AACR 2020 – Changing the Immunotherapy Paradigm
2020-05-08
AACR Conference – Major Highlights of Immunotherapy Clinical Trials
2020-04-30
R&D
AACR 2020 Conference – Advances in the Field of Lung Cancer Targeted Therapies
2020-04-28
Keytruda Flounders Lung Cancer Trial but Scores Key Win for Bladder Cancer
2020-01-14
European approval of Pembrolizumab for resected Stage III melanoma – KN-54 excerpts
2018-12-21
New hepatocellular carcinoma approval for Pembrolizumab – KN-224
2018-11-14
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top